Electromed Inc
AMEX:ELMD
Electromed Inc
Electromed, Inc. engages in the development, manufacture, marketing, and sale of medical equipment. The company is headquartered in New Prague, Minnesota and currently employs 156 full-time employees. The company went IPO on 2010-08-13. The firm applies High Frequency Chest Wall Oscillation (HFCWO) technologies in pulmonary care for patients of all ages. The company markets SmartVest Airway Clearance System (SmartVest System) which includes SmartVest SQL and SV2100 and related products, to patients with compromised pulmonary function. The SmartVest System features a programmable air pulse generator, a therapy garment worn over the upper body and a connecting hose, which together provide safe airway clearance therapy. The SmartVest SQL is smaller, quieter and lighter with programmability and ease of use. The company offers SmartVest SQL with SmartVest Connect wireless technology. The SmartVest Connect app allows patients and healthcare teams to track therapy in real-time and collaborate on care decisions to improve therapy adherence and patient outcomes. The company also offers single patient use (SPU) SmartVest and SmartVest Wrap to health care providers.
Electromed, Inc. engages in the development, manufacture, marketing, and sale of medical equipment. The company is headquartered in New Prague, Minnesota and currently employs 156 full-time employees. The company went IPO on 2010-08-13. The firm applies High Frequency Chest Wall Oscillation (HFCWO) technologies in pulmonary care for patients of all ages. The company markets SmartVest Airway Clearance System (SmartVest System) which includes SmartVest SQL and SV2100 and related products, to patients with compromised pulmonary function. The SmartVest System features a programmable air pulse generator, a therapy garment worn over the upper body and a connecting hose, which together provide safe airway clearance therapy. The SmartVest SQL is smaller, quieter and lighter with programmability and ease of use. The company offers SmartVest SQL with SmartVest Connect wireless technology. The SmartVest Connect app allows patients and healthcare teams to track therapy in real-time and collaborate on care decisions to improve therapy adherence and patient outcomes. The company also offers single patient use (SPU) SmartVest and SmartVest Wrap to health care providers.
Record Revenue: Electromed posted record Q2 revenue of $18.9 million, up 16.3% year-over-year, marking the 13th straight quarter of revenue and profit growth.
Homecare Strength: The core homecare business grew 18.4% YoY, with distributor channel revenue up 12.1%, while hospital sales declined due to shipment prioritization.
Profitability: Operating income climbed 42.4% to $3.6 million, with EPS rising to $0.32 from $0.22 last year.
Strong Margins: Gross profit margin improved to 78.4%, with continued focus on operational efficiency and manufacturing optimization.
Sales Force Expansion: The company averaged 58 direct sales reps and plans to reach 61 by year-end, maintaining annual productivity guidance of $1 million to $1.1 million per rep.
Shareholder Returns: Electromed has $13.8 million in cash, no debt, and an active $10 million stock repurchase program.
Strategic Focus: Management highlighted a large untapped bronchiectasis market, continued awareness-building campaigns, and new payer contracts covering 2.9 million additional lives.
